FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced it has conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph nodes …
Read More